Well Told Grants

Federal grant programs / Department of Health and Human Services

The Innovative Cardiovascular Health Program (93.435)

The Innovative Cardiovascular Health Program (Assistance Listing 93.435) is run by the Centers for Disease Control and Prevention, part of the Department of Health and Human Services. It awarded $74.4 million in 28 grants from fiscal 2021 to 2025, about $2.7 million per award on average. No funding opportunity is open on Grants.gov right now.

The typical award was $2.9 million. Half of the 28 awards fell between $1.6 million and $3.6 million, and they ranged from $940,452 to $4.8 million.

Key findings

What the program funds

This program purpose is referencing unequal socioeconomic conditions and unfair opportunity structures have long existed and contribute to poor health outcomes in minority and ethnic populations and geographically and economically disadvantaged communities. Poverty, inferior housing and health care, and other debilitating social conditions are endemic to some communities, including Non-Hispanic Black (NHB), Hispanic, and Native American communities. Research highlights the high prevalence of cardiovascular disease (CVD), including hypertension, high cholesterol, and stroke in these groups. CVD is the leading cause of death in the US and stroke is the 5th leading cause with an estimated 1 in 9 health care dollars spent treating CVD. Despite significant decreases in CVD rates in the last 20 years, NHB continue to have higher CVD mortality rates than Non-Hispanic Whites (NHW). In 2019, NHB women and men younger than 65 were 2.0 and 1.3 times more likely to experience premature death from CVD than their NHW counterparts. In 2020, NHB had the highest heart disease mortality rates at 228.6 per 100,000 and stroke at 56.8 per 100,000. Uncontrolled hypertension is the primary contributor to morbidity and mortality rate disparities in CVD between NHB and other racial and ethnic groups. In 2019, NHB had more than double the age-adjusted death rates (56.7) attributable primarily to hypertension compared to NHW (25.7). Of the 1 in 2 US adults with hypertension, only 26.1% have controlled blood pressure. By age 55, the cumulative incidence of hypertension reaches almost 76% in NHB men and women, compared to 54.5% and 40.0% among NHW men and women, respectively. Moreover, NHB had a 1.5 to 2 times higher risk for hypertension after adjustment for other factors, regardless of baseline blood pressure. Among NHB adults who did not report a hypertension diagnosis, a larger proportion (28%) were unaware of hypertension (BP ?140/90 mm Hg) compared to NHW adults (16%). Despite the similar rate of hypertension treatment, only one-third of NHB adults had their blood pressure controlled, in contrast to 45.0% of NHW adults. These data clearly indicate that NHB bear the greatest burden of CVD among US adults. The outcomes are as stark in other CVD-related illnesses. Although the prevalence of high cholesterol in NHB is comparable to or lower than in NHW, racial-ethnic disparities occur at every level of diagnosis and management. The disparities present in low screening rates, fewer prescriptions, and medication adherence. Unsatisfactory control of high cholesterol among NHB stems from the same adverse social conditions that hinder the control of hypertension. Interventions must include an understanding of individual and community factors that influence a healthy diet, losing weight, being physically active, and medication adherence to address the disparities and inequities. There is a need for equity-focused health system interventions to prevent, detect, control, and manage hypertension and high cholesterol. Building on lessons from the previous work, this program focuses on comprehensive efforts to identify and respond to health care disparities and improve CVD-related outcomes, specifically for those with hypertension and high cholesterol. Populations of focus for this program are adults aged 18 and older with a hypertension crude prevalence of 53% or higher, as shown by data specifically at the census tract level. Emphasis should be placed on achieving impact and reach across geographic locations where disparate populations can benefit from the strategies included in this program.

Open opportunities

No opportunity under this program is open or forecast on Grants.gov right now. Programs often post once a year, so the funding history below shows what to expect.

Funding history and past recipients

From fiscal 2021 to 2025, The Innovative Cardiovascular Health Program (93.435) awarded $74.4 million across 28 grant awards, an average of $2.7 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
County of Los AngelesCalifornia1$4.8 million
Fund for Public Health in New York, Inc.New York1$4.0 million
Minnesota Department of HealthMinnesota1$4.0 million
Health Research, Inc.New York1$4.0 million
Michigan Department of Health and Human ServicesMichigan1$4.0 million
Utah Department of Health and Human ServicesUtah1$4.0 million
Colorado Department of Public Health & EnvironmentColorado1$3.6 million
State of Wisconsin Department of Health ServicesWisconsin1$3.6 million
Virginia Department of HealthVirginia1$3.5 million
Massachusetts Department of Public HealthMassachusetts1$3.3 million
Prince George's County, MarylandMaryland1$3.1 million
Missouri Department of Health & Senior ServicesMissouri1$3.1 million
State of Rhode Island Department of HealthRhode Island1$3.0 million
State of Montana Department of Health and Human ServicesMontana1$3.0 million
South Carolina Department of Public HealthSouth Carolina1$2.7 million
Illinois Public Health InstituteIllinois1$2.4 million
Philadelphia City OfficePennsylvania1$2.4 million
Health Services Kentucky Cabinet forKentucky1$1.9 million
County of San DiegoCalifornia1$1.8 million
Department of State Health ServicesTexas1$1.7 million

Top states: New York ($8.0 million), California ($7.5 million), Michigan ($4.0 million), Minnesota ($4.0 million), Utah ($4.0 million), Colorado ($3.6 million), Wisconsin ($3.6 million), Virginia ($3.5 million), Massachusetts ($3.3 million), Maryland ($3.1 million).

Who usually wins

State and local governments received 85% of the money, colleges and universities 11% and nonprofits 4.1%.

Recipient typeAwardsAmountShare
State and local governments25$63.4 million85%
Colleges and universities2$8.0 million11%
Nonprofits1$3.1 million4.1%

By state

Each state below has its own page for this program, with its recipients and yearly totals.

Grants by recipient's state, fiscal 2021 to 2025
StateAwardsAmount
New York2$8.0 million
California3$7.5 million
Michigan1$4.0 million
Minnesota1$4.0 million
Utah1$4.0 million
Colorado1$3.6 million
Wisconsin1$3.6 million
Virginia1$3.5 million
Massachusetts1$3.3 million
Maryland1$3.1 million
Missouri1$3.1 million
Montana1$3.0 million
Rhode Island1$3.0 million
South Carolina1$2.7 million
Illinois1$2.4 million
Pennsylvania1$2.4 million
Kentucky1$1.9 million
Texas1$1.7 million
North Carolina1$1.7 million
Kansas1$1.6 million
Louisiana1$1.5 million
Nevada1$1.4 million
Georgia1$1.3 million
Florida1$1.2 million
Washington1$1.2 million

Award amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.